Medilines on track with P2-B revenue goal | Inquirer Business
Expanding consumables business

Medilines on track with P2-B revenue goal

/ 02:03 AM September 13, 2022

Medical equipment distributor Medilines Distributors Inc., which recently celebrated its 20th year of operations, remains firm on providing critical care devices for the local health-care industry.

In a statement on Monday, the listed company said it was keen on expanding the consumable business to achieve P2 billion revenues this year, exceeding its 2021 performance.

It inaugurated earlier this year a new warehouse facility to store and handle delicate consumables, including dialyzers, bloodline systems, concentrates, fluid filters, cannula and catheter.

Article continues after this advertisement

Medilines chair Virgilio Vilar said they intended to maintain their partnerships with local and foreign companies as well to “pursue the company’s goals for the next decades.”

FEATURED STORIES

“It is important for us to maintain the strong partnerships we have cultivated with our principals,” he said.

“At the same time, we are also open to new opportunities. It is also Medilines’ goal to maintain dominance in the health-care equipment market through its continuous participation in major, capital intensive projects,” he added.

—Tyrone Jasper C. Piad INQ
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Business, Medilines Distributors Inc.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.